IKS Health has announced the grant of 131,114 employee stock options to eligible employees under its Employee Stock Option Plan 2022 (IKS ESOP Plan). The grant was approved by the Nomination and Remuneration Committee on June 16, 2026. Each option is convertible into one fully paid-up equity share of face value Re. 1. The exercise price is set at Re. 1 per Option.
Employee Stock Option Grant Announced
IKS Health has officially announced a significant grant of employee stock options. On June 16, 2026, the company approved the grant of 131,114 employee stock options. These options are being issued to eligible employees under the framework of the company’s established Employee Stock Option Plan 2022, referred to as the “IKS ESOP Plan.” The approval for this grant was given by the Nomination and Remuneration Committee of the Board of Directors.
Key Details of the ESOP Grant
Each granted option provides the holder with the right to acquire one fully paid-up equity share of the company. These equity shares carry a face value of Re. 1 each. The exercise price for each option has been determined by the Nomination and Remuneration Committee to be Re. 1 per Option. In total, 131,114 equity shares of face value Re. 1/- each of the Company are covered by these options.
ESOP Plan Administration and Terms
The IKS ESOP Plan will be administered through a designated Trust. The terms of the plan stipulate that each option, upon exercise, will be converted into One (1) Equity Share with a face value of Re.1. The scheme also outlines provisions for handling stock options in various situations such as death, permanent incapacity, resignation, termination, or retirement of an employee. Furthermore, in the event of corporate actions like rights issues, bonus issues, share splits, or mergers, requisite adjustments to the options will be made fairly and reasonably according to the IKS ESOP Plan. Importantly, equity shares allotted from exercising these options will not be subject to any lock-in period.
Source: BSE
